Sentinel lymph node dissection is a minimally invasive surgical technique f
or staging of breast carcinoma. The optimal pathologic examination of the s
entinel node (SN) has not yet been determined. Our standard protocol for ev
aluation of the SN in patients with breast cancer included frozen section a
t one level, plus paraffin sections at two levels, separated by 40 mu m, an
d stained with hematoxylin and eosin and cytokeratin immunohistochemistry (
IHC) at each paraffin section level. In the current study, we evaluated the
use of step sections and cytokeratin IHC in 60 SNs (42 consecutive patient
s) that were tumor-negative on frozen section and hematoxylin and eosin sta
ining at permanent section levels 1 and 2. The SN were reexamined with cyto
keratin MC at eight additional levels (levels 3-10) of the paraffin block,
each separated by 40 mu m. Previous IHC sections from levels 1 and 2 had sh
own micrometastases in nine SNs (eight patients) and no tumor cells in the
remaining 51 SNs (34 patients). Of the 51 previously negative SNs, only two
(4%) SNs from one (3%) patient had metastatic carcinoma cells in levels 3-
10. Thus, the additional step sections with cytokeratin IHC did not signifi
cantly increase the number of patients with tumor-positive SNs, We currentl
y recommend that the SN be examined with cytokeratin MC at two levels of th
e paraffin block. This should optimize sentinel lymph node dissection as a
staging technique and minimize the labor and financial burden associated wi
th multiple step sections and IHC stains.